
Arthroplasty
TKA: Patient-specific guides offer no accuracy benefit over conventional instrumentation
This report has been verified
by one or more authors of the
original publication.
Clin Orthop Relat Res. 2014 Jan;472(1):263-71. doi: 10.1007/s11999-013-2997-4
128 patients scheduled for total knee arthroplasty were randomized to intervention with either patient-specific guides (PSG) or conventional instrumentation. Participants allocated to PSG were managed with pre-operative planning using either Signature (Biomet Inc.), TruMatch (Depuy Inc.), Visionaire (Smith & Nephew Inc.), or Patient-Specific Instruments (Zimmer Inc.). Patients allocated to the conventional group were treated with standard intra- and extramedullary instrumentation. The results indicated that there was no significant improvement over conventional instrumentation offered by PSGs. Additionally, PSGs had to be abandoned intraoperatively in 14 cases, and outliers in tibial component alignment were significantly higher in the PSG cohort.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.